Thomas YBERT
@thomasybertds
ID: 2376901746
07-03-2014 10:20:37
12 Tweet
105 Followers
39 Following
Welcome #lifescience veteran Chris Barbazette as our new Chief Commercial Officer. He will play a pivotal role in driving our continued commercial growth. We're thrilled he has joined the team! More: ow.ly/PLV050J3RVw #biotech #leadership #enzymaticDNAsynthesis #DNAonDemand
Today we launched next-gen kits for same-day #qPCR from design to results, as well as other #genomics applications. With the printing of longer oligos and labeled probes, these advances promise to expedite workflows to accelerate discovery! ow.ly/L0Ib50Jqm5S AGBT Meeting #AGBT2022
Today we announced the first successful #qPCR assays using primers & probes, synthesized via #EnzymaticSynthesis using #SYNTAX, for the detection of infectious disease and biothreats. This was achieved in liaison with the Direction générale de l'armement 🇫🇷. More: ow.ly/QMBn50JJt2K #DNAonDemand
In Forbes Technology Council, DNA Script's Gariel Sylvain talks about something he calls “assay streaming,” enabling facilities distributed globally to produce a standardized assay in response to an emerging biothreat the moment the assay is validated. Read more: ow.ly/MOSl50KkilL
Thanks to @FionaRMischel & the SynBioBeta podcast for great convo exploring "How DNA Will Make Our Future?" We explored why we make DNA and what role these fundamental molecules will play in the future of the bioeconomy. More: ow.ly/amV350KroMT #DNAsynthesis #syntheticDNA